Development of a Fluorescent Multiplex Assay for Detection of MSI‐High Tumors
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Determining whether a tumor exhibits microsatellite instability (MSI) is useful in identifying patients with hereditary non‐polyposis colorectal cancer and sporadic gastrointestinal cancers with defective DNA mismatch repair (MMR). The assessment of MSI status aids in establishing a clinical prognosis and may be predictive of tumor response to chemotherapy. A reference panel of five markers was suggested for MSI analysis by a National Cancer Institute (NCI) workshop in 1997 that has helped to standardize testing. But this panel of markers has limitations resulting from the inclusion of dinucleotide markers, which are less sensitive and specific for detection of tumors with MMR deficiencies compared to other types of markers that are currently available. This study demonstrates that mononucleotides are the most sensitive and specific markers for detection of tumors with defects in MMR and identifies an optimal panel of markers for detection of MSI‐H tumors. A set of 266 mono‐, di‐, tetra‐ and penta‐nucleotide repeat microsatellite markers were used to screen for MSI in colorectal tumors. The best markers for detection of MSI‐H tumors were selected for a MSI Multiplex System, which included five mononucleotide markers: BAT-25, BAT-26, NR-21, NR-24 and MONO-27. In addition, two pentanucleotide markers were added to identify sample mix‐ups and/or contamination. We classified 153 colorectal tumors using the new MSI Multiplex System and compared the results to those obtained with a panel of 10 microsatellite markers combined with immunohistochemical (IHC) analysis. We observed 99% concordance between the two methods with nearly 100% accuracy in detection of MSI‐H tumors. Approximately 5% of the MSI‐H tumors had normal levels of four MMR proteins and as a result would have been misclassified based solely on IHC analysis, emphasizing the importance of performing MSI testing. The new MSI Multiplex System offers several distinct advantages over other methods of MSI testing in that it is both extremely sensitive and specific and amenable to high‐throughput analysis. The MSI Multiplex System meets the new recommendations proposed at the recent 2002 NCI workshop on HNPCC and MSI testing and overcomes problems inherent to the original five‐marker panel. The use of a single multiplex fluorescent MSI assay reduces the time and costs involved in MSI testing with increased reliability and accuracy and thus should facilitate widespread screening for microsatellite instability in tumors of patients with gastrointestinal cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“STR loci are known to vary in the presence of microsatellite instability, with the degree of variability depending on the locus being assessed.16,28,43”
From Match criteria for human cell line authentication: Where do we draw the line? (2013) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Boland, C. R., Thibodeau, S. N., Hamilton, S. R., Sidransky, D., Eshleman, J. R., Burt, R. W., Meltzer, S. J., Rodrı́guez-Bigas, M. A., Fodde, R., Ranzani, G. N., et al. (1998) · PubMed · Cited by 4,087
Self-citationUmar, A., Boland, C. R., Terdiman, J. P., Syngal, S., Chapelle, A. D. L., Ruschoff, J., Fishel, R., Lindor, N. M., Burgart, L. J., Hamelin, R., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh034 · Cited by 3,183
Self-citationMicrosatellite Instability in Cancer of the Proximal Colon
Thibodeau, S. N., Bren, G., & Schaid, D. (1993) · Science · doi:10.1126/science.8484122 · Cited by 3,130 · cited 2×
“ity (MSI), which is characterized by alterations in the length of short tandem repeats in tumor DNA [1,16,44].”
BackgroundResultSelf-citationThe human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer
Fishel, R., Lescoe, M. K., Rao, M. R. S., Copeland, N. G., Jenkins, N. A., Garber, J., Kane, M., & Kolodner, R. (1993) · Cell · doi:10.1016/0092-8674(93)90546-3 · Cited by 2,873 · cited 1×
“Microsatellite instability is caused by DNA mismatch repair (MMR) deficiency and subsequent failure to repair errors introduced during replication of DNA [6,11, 22].”
BackgroundClues to the Pathogenesis of Familial Colorectal Cancer
Aaltonen, L. A., Peltomäki, P., Leach, F. S., Sistonen, P., Pylkkänen, L., Mecklin, J.-P., Järvinen, H., Powell, S. M., Jen, J., Hamilton, S. R., et al. (1993) · Science · doi:10.1126/science.8484121 · Cited by 2,710 · cited 2×
“MSI-H tumors are more likely to have mutations in genes with short repetitive tracts includingTGF-βRII, BAX, IGF2R genes [27,30, 32,34,42,50] and less likely to have loss of APC [1,15, 31,38] or have mutations in p53 [1,7,24,31,38,41] and K-ras genes [1,24,31,38].”
BackgroundIonov, Y., Peinado, M. A., Malkhosyan, S., Shibata, D., & Perucho, M. (1993) · Nature · doi:10.1038/363558a0 · Cited by 2,708 · cited 1×
“ity (MSI), which is characterized by alterations in the length of short tandem repeats in tumor DNA [1,16,44].”
BackgroundMutations of a mutS homolog in hereditary nonpolyposis colorectal cancer
Leach, F. S., Nicolaides, N. C., Papadopoulos, N., Liu, B., Jen, J., Parsons, R., Peltomäki, P., Sistonen, P., Aaltonen, L. A., Nyström-Lahti, M., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90330-s · Cited by 2,276 · cited 1×
“Microsatellite instability is caused by DNA mismatch repair (MMR) deficiency and subsequent failure to repair errors introduced during replication of DNA [6,11, 22].”
BackgroundInactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite Instability
Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., et al. (1995) · Science · doi:10.1126/science.7761852 · Cited by 2,270 · cited 1×
“MSI-H tumors are more likely to have mutations in genes with short repetitive tracts includingTGF-βRII, BAX, IGF2R genes [27,30, 32,34,42,50] and less likely to have loss of APC [1,15, 31,38] or have mutations in p53 [1,7,24,31,38,41] and K-ras genes [1,24,31,38].”
BackgroundRibic, C. M., Sargent, D. J., Moore, M. J., Thibodeau, S. N., French, A. J., Goldberg, R. M., Hamilton, S. R., Laurent-Puig, P., Gryfe, R., Shepherd, L. E., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022289 · Cited by 2,160
Self-citationBronner, C. E., Baker, S. M., Morrison, P. T., Warren, G., Smith, L. G., Lescoe, M. K., Kane, M., Earabino, C., Lipford, J., Lindblom, A., et al. (1994) · Nature · doi:10.1038/368258a0 · Cited by 2,052 · cited 1×
“Microsatellite instability is caused by DNA mismatch repair (MMR) deficiency and subsequent failure to repair errors introduced during replication of DNA [6,11, 22].”
Background
Cited by
Items 101–200 of 300
DNA Mismatch Repair Defects and Microsatellite Instability Status in Periocular Sebaceous Carcinoma
Rajan, A., Burris, C. K. H., Iliff, N. T., Grant, M. P., Eshleman, J. R., & Eberhart, C. G. (2013) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2013.12.002 · Cited by 30
An individual with Muir-Torre syndrome found to have a pathogenic MSH6 gene mutation
Arnold, A. G., Payne, S. J., Fisher, S., Fricker, D., Soloway, J. R., White, S. M., Novelli, M. R., MacDonald, K., Mackay, J., Groves, R. W., et al. (2007) · Familial Cancer · doi:10.1007/s10689-007-9119-y · Cited by 30
The analysis of microsatellite instability in extracolonic gastrointestinal malignancy
Williams, A. S., & Huang, W. (2013) · Pathology · doi:10.1097/pat.0b013e3283653307 · Cited by 29
“There are certain morphological features that suggest MSI-H CRC and international guidelines have been established for the evaluation of MSI in CRC.”
BackgroundInfluentialMicrosatellite instability in Japanese female patients with triple-negative breast cancer
Kurata, K., Kubo, M., Kai, M., Mori, H., Kawaji, H., Kaneshiro, K., Yamada, M., Nishimura, R., Osako, T., Arima, N., et al. (2020) · Breast Cancer · doi:10.1007/s12282-019-01043-5 · Cited by 29
Identifying Optimal Loci for the Molecular Diagnosis of Microsatellite Instability
Long, D. R., Waalkes, A., Panicker, V., Hause, R. J., & Salipante, S. J. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvaa177 · Cited by 28
“Molecular diagnosis of MSI in clinical practice is most commonly achieved using multiplexed PCR of defined microsatellite loci, followed by capillary electrophoresis to detect new alleles (MSI-PCR) qualitatively (17, 18).”
BackgroundMethodInfluentialValidation of Long Mononucleotide Repeat Markers for Detection of Microsatellite Instability
Lin, J. H., Chen, S., Pallavajjala, A., Guedes, L. B., Lotan, T. L., Bacher, J. W., & Eshleman, J. R. (2021) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2021.10.011 · Cited by 28
Self-citationRelative Risk of Bladder and Kidney Cancer in Lynch Syndrome: Systematic Review and Meta-Analysis
Nassour, A., Jain, A., Hui, N., Siopis, G., Symons, J., & Woo, H. H. (2023) · Cancers · doi:10.3390/cancers15020506 · Cited by 29
“This enables the inspection of simultaneous targets with a resolution of up to a single base difference [66,67].”
BackgroundBai, H., Wang, R., Cheng, W., Shen, Y., Li, H., Xia, W., Ding, Z., & Zhang, Y. (2020) · Cancer Management and Research · doi:10.2147/cmar.s248069 · Cited by 27
Wu, C., Huang, L., & Chang, C. L. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.07.006 · Cited by 26
“, MSI) in colorectal cancer patients is routinely determined by the PCR-based assay with microsatellite markers [27].”
MethodAlbayrak, A., Garrido-Castro, A. C., Giannakis, M., Umeton, R., Manam, M. D., Stover, E. H., Porter, R. L., Johnson, B. E., Liaw, K., Amonkar, M. M., et al. (2020) · JCO Precision Oncology · doi:10.1200/po.20.00185 · Cited by 25
Bujalkova, M. G., Závodná, K., Krivulcik, T., Ilenčíková, D., Wolf, B., Kovac, M. B., Karner‐Hanusch, J., Heinimann, K., Marra, G., Jiricny, J., et al. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.108902 · Cited by 25
Li, X., Larsson, P. G., Ljuslinder, I., Ling, A., Löfgren‐Burström, A., Zingmark, C., Edin, S., & Palmqvist, R. (2021) · Pathology - Research and Practice · doi:10.1016/j.prp.2021.153379 · Cited by 23
Chen, J., Yan, Q., Sun, J., Wang, Q., Tao, Y., Xiao, D., & Xie, B. (2023) · Journal of Cancer · doi:10.7150/jca.81675 · Cited by 22
“In 2004, Promega developed a panel that is more sensitive and specific, using five monomorphic mononucleotide makers (BAT-25, BAT-26, NR-21, NR-24, and MONO-27) and two pentanucleotide markers (Penta C and Penta D) as homology controls [19].”
MethodLiu, Y. L., & Weigelt, B. (2024) · Cancer · doi:10.1002/cncr.35267 · Cited by 22
“23 A tumor is classified as MSI ‐”
BackgroundPrevalence and Associations of Beta2-Microglobulin Mutations in MSI-H/dMMR Cancers
Liu, F., Zhong, F., Wu, H., Che, K., Shi, J., Wu, N., Fu, Y. S., Wang, Y., Hu, J. Y., Qian, X., et al. (2023) · The Oncologist · doi:10.1093/oncolo/oyac268 · Cited by 22
Roy, P., Nayak, S., Arora, N., Arun, I., Roy, M. K., Banerjee, S., Mallick, I., & Mallath, M. K. (2018) · Indian Journal of Pathology and Microbiology · doi:10.4103/ijpm.ijpm_430_17 · Cited by 21
“IHC estimation of MMR deficiency has similar efficacy to PCR based MSI with a sensitivity close to 95% and specificity of 98%.[18,19] This is much improved with four MMR IHC markers, over earlier studies using two antibody panels (MLH1 and MSH2).”
Jang, M., Kwon, Y., Kim, H., Kim, H., Min, B. S., Park, Y., Kim, T. I., Hong, S. P., & Kim, W. K. (2018) · BMC Cancer · doi:10.1186/s12885-018-5127-6 · Cited by 21
Yu, F., Leong, K. W., Makrigiorgos, A., Adalsteinsson, V. A., Ladas, I., Ng, K., Mamon, H. J., & Makrigiorgos, G. M. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa1175 · Cited by 21
Hirotsu, Y., Nagakubo, Y., Amemiya, K., Oyama, T., Mochizuki, H., & Omata, M. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.11.002 · Cited by 21
Clinical Testing for Mismatch Repair in Neoplasms Using Multiple Laboratory Methods
Yang, R. K., Chen, H., Roy‐Chowdhuri, S., Rashid, A., Álvarez, H., Routbort, M. J., Patel, K. P., Luthra, R., Medeiros, L. J., & Törüner, G. (2022) · Cancers · doi:10.3390/cancers14194550 · Cited by 20
Carrato, C., Sanz, C., Muñoz-Mármol, A. M., Blanco, I., Pineda, M., Valle, J. D., Dámaso, E., Esteller, M., & Musulén, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094629 · Cited by 20
“NR27 is one of the five markers of the quasi-monomorphic panel (NR21, NR27, NR24, BAT25 and BAT26) described by Buhard et al [70] and different from those validated in colorectal cancer due to its better specificity, which allows the avoidance of normal cells as a control [73].”
BackgroundMolecular Genetics of Prostate Cancer and Role of Genomic Testing
Akhoundova, D., Feng, F. Y.-C., Pritchard, C. C., & Rubin, M. A. (2022) · Surgical pathology clinics · doi:10.1016/j.path.2022.08.002 · Cited by 20
Kohlruss, M., Ott, K., Grosser, B., Jesinghaus, M., Slotta‐Huspenina, J., Novotny, A., Hapfelmeier, A., Schmidt, T., Gaida, M. M., Weichert, W., et al. (2021) · Cancers · doi:10.3390/cancers13051048 · Cited by 19
“Due to the high sensitivity and specificity of mononucleotide repeat markers to detect MSI-H and thus to avoid a classification as MSI-H based on instabilities exclusively at two dinucleotide repeats, those tumors were additionally analyzed using three mononucleotide markers NR-21, NR-24 and NR27 as described in detai…”
MethodKohlruss, M., Krenauer, M., Grosser, B., Pfarr, N., Jesinghaus, M., Slotta‐Huspenina, J., Novotny, A., Hapfelmeier, A., Schmidt, T., Steiger, K., et al. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01587-4 · Cited by 19
Filiform polyposis: A benign entity? Case report and literature review
Boulagnon‐Rombi, C., Jazeron, J.-F., Cives, A. D., Ehrhard, F., Bouché, O., & Diébold, M.-D. (2013) · Pathology - Research and Practice · doi:10.1016/j.prp.2013.11.001 · Cited by 19
A Highly Sensitive Pan-Cancer Test for Microsatellite Instability
Bacher, J. W., Udho, E. B., Strauss, E. E., Vyazunova, I., Gallinger, S., Buchanan, D. D., Pai, R. K., Templeton, A. S., Storts, D. R., Eshleman, J. R., et al. (2023) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2023.07.003 · Cited by 18
“50,82 For example, a panel of quasi-monomorphic mononucleotide-repeat markers ( NR-21, NR-24, BAT-25, BAT-26, MONO-27 ) (FALCO biosystems, Kyoto, Japan) was approved as a companion diagnostic for pem-brolizumab for the treatment of MSI-H solid tumors without requiring the use of matching normal…”
BackgroundSelf-citationHaines, J. W., Bacher, J. W., Coster, M., Huiskamp, R., Meijne, E. I. M., Mancuso, M., Pazzaglia, S., & Bouffler, S. D. (2010) · International Journal of Radiation Biology · doi:10.3109/09553001003734600 · Cited by 18
“The PCR protocol used was as reported by Bacher et al. (2005). Separation and detection of the amplified fragments was performed using an ABI PRISM 3100 Genetic Analyser (Applied Biosystems, Foster City, CA, USA) (Figure 2).”
MethodResultSelf-citationMismatch repair status and high expression of PD-L1 in nasopharyngeal carcinoma
Zhao, L., Liao, X., Hong, G., Zhuang, Y., Fu, K., Chen, P., Wang, Y., Chen, H., & Lin, Q. (2019) · Cancer Management and Research · doi:10.2147/cmar.s193878 · Cited by 18
“We used the MSI Multiplex System (Promega, Madison, WI, USA) with five mononucleotide markers for the detection of MSI: NR-21, BAT-26, BAT-25, NR-24, and MONO-27.(17) Separation and detection of amplified fragments were performed on an ABI PRISM 3500 Genetic Analyzer (Applied Biosystems, Foster City, CA, USA) followin…”
BackgroundMethodInfluentialKamat, N., Khidhir, M. A., Jaloudi, M., Hussain, S., Alashari, M., Qawasmeh, K. H. A. A., & Rannug, U. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-373 · Cited by 18
MSIFinder: a python package for detecting MSI status using random forest classifier
Zhou, T., Chen, L., Guo, J., Zhang, M., Zhang, Y., Cao, S., Lou, F., & Wang, H. (2021) · BMC Bioinformatics · doi:10.1186/s12859-021-03986-z · Cited by 18
Mismatch repair deficiency testing in Lynch syndrome-associated urothelial tumors
Rasmussen, M., Sowter, P., Gallon, R., Durhuus, J. A., Hayes, C. M., Andersen, O., Nilbert, M. C., Schejbel, L., Høgdall, E. V. S., Santibanez‐Koref, M., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1147591 · Cited by 17
“2, including mononucleotide repeat markers BAT-25, BAT-26, NR-21, NR-24, and MONO-27 plus two control pentanucleotide repeat markers to distinguish between samples and detect possible contamination (14).”
BackgroundShin, G. W., Greer, S., Hopmans, E. S., Grimes, S. M., Lee, H., Zhao, L., Miotke, L. K., Suarez, C. J., Almeda, A. F., Haraldsdóttir, S., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00958-z · Cited by 17
“The MSI PCR test uses a multiplexed amplicon assay which requires testing five or more microsatellite markers—typically these are either mono- or dinucleotide repeats [3, 4].”
MethodSporadic breast cancer patients' germline DNA exhibit an AT‐rich microsatellite signature
Galindo, C. L., McIver, L. J., Tae, H., McCormick, J. F., Skinner, M. A., Hoeschele, I., Lewis, C. M., Minna, J. D., Boothman, D. A., & Garner, H. R. (2011) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20853 · Cited by 17
“This extensively used ‘‘gold standard’’ for classification of MSI is based upon the analysis of only five intergenic poly-A repeats (Bacher et al., 2004), out of a total of 169,315 poly-A and poly-T Figure 3.”
MethodHayashida, G., Shioi, S., Hidaka, K., Fujikane, R., Hidaka, M., Tsurimoto, T., Tsuzuki, T., Oda, S., & Nakatsu, Y. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.02.020 · Cited by 17
Low level of microsatellite instability in paediatric malignant astrocytomas
Vladimirova, V. A., Denkhaus, D., Soerensen, N., Wagner, S., Wolff, J. E. A., & Pietsch, T. (2008) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2007.00919.x · Cited by 17
Immunohistology of the Female Genital Tract
Soslow, R. A., Isacson, C., & Zaloudek, C. J. (2006) · Elsevier eBooks · doi:10.1016/b978-0-443-06652-8.50022-3 · Cited by 16
Molecular testing for microsatellite instability and its value in tumor characterization
Kloor, M., Doeberitz, M. V. K., & Gebert, J. F. (2005) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.5.4.599 · Cited by 16
Vail, E., Song, J., Xu, J., Frye, J. S., Kim, J. T., Pao, A., Schreck, R. R., Aguiluz, A., Zhang, W., Alkan, S., et al. (2020) · Targeted Oncology · doi:10.1007/s11523-020-00743-9 · Cited by 15
Advances in Biomarkers: Going Beyond the Carcinoembryonic Antigen
Lopez, N., & Peterson, C. Y. (2016) · Clinics in Colon and Rectal Surgery · doi:10.1055/s-0036-1584289 · Cited by 15
N_LyST: a simple and rapid screening test for Lynch syndrome
Susanti, S., Fadhil, W., Ebili, H. O., Asiri, A., Nestarenkaitė, A., Hadjimichael, E., Ham-Karim, H. A., Field, J., Stafford, K., Matharoo‐Ball, B., et al. (2018) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2018-205013 · Cited by 15
Boulagnon‐Rombi, C., Dudez, O., Beaudoux, O., Dalstein, V., Kianmanesh, R., Bouché, O., & Diébold, M.-D. (2015) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000157 · Cited by 15
Deng, B., Park, J., Ren, L., Yew, P. Y., Kiyotani, K., Antic, T., O'Connor, K., O’Donnell, P. H., & Nakamura, Y. (2018) · Cancer Reports · doi:10.1002/cnr2.1002 · Cited by 14
“Genomic DNAs were used for MSI analysis with the Promega panel according to the manufacturer's protocol (5 mononucleotide markers: BAT‐25, BAT‐26, NR‐21, NR‐24, and MONO‐27; and 2 pentanucleotide markers for identifying sample mix‐ups and/or contamination: Penta C and Penta D).(45) The PCR products were analyzed by ca…”
MethodThe Influence of Heavy Metals on Gastric Tumorigenesis
Wang, L., Miao, C., He, Y., Li, H., Zhang, S., Li, K., Liu, H., Li, W., Zhao, J., Xu, Y., et al. (2022) · Journal of Oncology · doi:10.1155/2022/6425133 · Cited by 14
“3ese regions are amplified from both tumor and nontumor tissues by fluorescent multiplex PCR, and their sizes were assessed by capillary electrophoresis [39, 40].”
MethodRasmussen, S. V., Jin, J. X., Bickford, L. R., Woods, A. D., Sahm, F., Crawford, K. A., Nagamori, K., Goto, H., Torres, K. E., Sidoni, A., et al. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.961 · Cited by 14
Assessment of microsatellite instability in head and neck cancer using consensus markers
Yalniz, Z., Demokan, S., Süoğlu, Y., Ulusan, M., & Dalay, N. (2010) · Molecular Biology Reports · doi:10.1007/s11033-010-0001-x · Cited by 14
Wang, C., Muzakky, H., Lee, Y., Chung, Y.-P., Wang, Y., Yu, M.-H., Wu, C.-H., & Chao, T. (2025) · Computerized Medical Imaging and Graphics · doi:10.1016/j.compmedimag.2025.102499 · Cited by 13
Assessment of Microsatellite Instability from Next-Generation Sequencing Data
Renault, V., Tubacher, E., & How‐Kit, A. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-91836-1_5 · Cited by 13
A robust method for the rapid detection of microsatellite instability in colorectal cancer
Zhao, L., Shan, G., Li, L., Yu, Y., Cheng, G., & Xu, Z. (2020) · Oncology Letters · doi:10.3892/ol.2020.11702 · Cited by 13
Imamura, Y., Toihata, T., Haraguchi, I., Ogata, Y., Takamatsu, M., Kuchiba, A., Tanaka, N., Gotoh, O., Mori, S., Nakashima, Y., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.33322 · Cited by 13
Ebinger, M., Sotlar, K., Weber, A., Bock, C. –., Bültmann, B., & Kandolf, R. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.2005.028217 · Cited by 12
Jian, D., Lu, X., Wang, D., Li, M., Yang, Y., Chen, Q., Qian, C., Shao, W., Dai, N., & Feng, Y. (2022) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2022.152024 · Cited by 11
Babaei, H., Zeinalian, M., Emami, M. H., Hashemzadeh, M., Farahani, N., & Salehi, R. (2017) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2016.0091 · Cited by 11
A novel method for biodosimetry
Megid, W. M. A., Ensenberger, M. G., Halberg, R. B., Stanhope, S. A., Kent-First, M. G., Prolla, T. A., & Bacher, J. W. (2006) · Radiation and Environmental Biophysics · doi:10.1007/s00411-006-0072-1 · Cited by 11
Self-citationCell Line Models of Molecular Subtypes of Colorectal Cancer
Mooi, J. K., Luk, I. Y., & Mariadason, J. M. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7765-9_1 · Cited by 11
Berginc, G., & Glavač, D. (2009) · Disease Markers · doi:10.1155/2009/901532 · Cited by 11
Faizee, M. I., Talib, N. A., Hamdan, A. H., Abdullah, N. Z., Rahimi, B. A., Haidary, A. M., Saadaat, R., & Hanifi, A. N. (2024) · Diagnostic Pathology · doi:10.1186/s13000-024-01571-5 · Cited by 10
“MSI analysis, applied on extracted tumour DNA, detects MSI status by Polymerase Chain Reaction (PCR) amplification of microsatellite areas, in which the length of microsatellite areas in tumour cells and normal cells from nearby normal tissue are compared [14, 15].”
Recent advances of macroporous hydrogel microparticles: Fabrication and applications
Liu, Y., Ling, S., Chen, Z., & Xu, J. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.161435 · Cited by 12
Bozdağ, L. A., İnan, S., & Gültekin, S. E. (2024) · Genes Chromosomes and Cancer · doi:10.1002/gcc.70002 · Cited by 10
“In this alternative approach, markers are amplified using fluorescent primers and then analyzed using capillary electrophoresis to determine the size of MSS alleles [81].”
Lee, Y., Lee, J. A., Park, H. E., Han, H., Kim, Y., Bae, J. M., Kim, J. H., Cho, N., Kim, H., Kim, T., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0246356 · Cited by 10
Toh, J. W. T., Singh, P., Tangirala, V. A. A. S. K., Limmer, A., & Spring, K. J. (2021) · Cells · doi:10.3390/cells10061401 · Cited by 10
“With IHC, there may be a 5–11% misclassification rate of MSI status in colorectal cancer [24,25].”
BackgroundThe State of the Art in Colorectal Cancer Molecular Biomarker Testing
Pillai, R. K., Lopategui, J. R., Dhall, D., Guindi, M. M., Slavin, T. P., Lofton–Day, C., & Patterson, S. D. (2016) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000107 · Cited by 10
Microsatellite Instability and its Significance to Hereditary and Sporadic Cancer
Bacher, J. W., Clipson, L. J., Steffen, L. S., & Halberg, R. B. (2016) · InTech eBooks · doi:10.5772/65065 · Cited by 10
“The MSI Analysis System has several advantages over the Bethesda panel, including: (1) increased sensitivity and specificity, (2) easier interpretation of MSI patterns in mononucleotide repeats compared to dinucleotide repeats, (3) the quasi-monomorphic nature of the markers simplifies analysis and allows MSI classifi…”
BackgroundMethodSelf-citationChung, Y., Nam, S. K., Chang, H. E., Lee, C., Kang, G. H., Lee, H. S., & Park, K. U. (2023) · BMC Cancer · doi:10.1186/s12885-023-11607-6 · Cited by 9
“Recently, a pentaplex panel with five mononucleotide repeat markers (BAT-25, BAT-26, NR-21, NR-24, and NR-27) was developed and is considered the current standard for PCR-based MSI assays [15–20].”
BackgroundMethodEvrard, C., Cortes, U., Ndiaye, B., Bonnemort, J., Martel, M., Aguillon, R., Tougeron, D., & Karayan, L. (2023) · Laboratory Investigation · doi:10.1016/j.labinv.2023.100297 · Cited by 9
Erill, N., Colomer, A., Calvo, M., Vidal, A., Roman, R. A., Verdú, M., Cordon‐Cardo, C., & Puig, X. (2005) · Journal of Molecular Diagnostics · doi:10.1016/s1525-1578(10)60578-8 · Cited by 9
“analogous multiplexed assays, including the most sensitive and specific consensus markers have been developed.(23,24) In this context, additional characteristics other than marker location, such as the repeat type, the frequency of heterozygosity, and the complexity of the peaks displayed, must be considered when deci…”
BackgroundKomori, A., Hironaka, S., Kadowaki, S., Mitani, S., Furuta, M., Kawakami, T., Makiyama, A., Takegawa, N., Sugiyama, K., Hirano, H., et al. (2024) · Gastric Cancer · doi:10.1007/s10120-024-01579-2 · Cited by 8
“Multiplex PCR fragment analysis (MSI testing kit, FALCO) was employed, utilizing fluorescently labeled primers for five mononucleotide markers (BAT-25, BAT-26, NR-21, NR-24, and MONO-27) [16].”
Microsatellite Instability of Nuclear and Mitochondrial DNAs in Gastric Carcinogenesis
Lee, J., & Kim, D.-K. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.19.8027 · Cited by 8
“…(Madison, USA) developed a fluorescent multiplex assay, called the MSI analysis system, which utilizes five mononucleotide microsatellite loci (BAT-25, BAT-26, NR-21, NR-24, and MONO-27) and two penta-nucleotide repeat markers (Penta C and Penta D) (Bacher et al., 2004; Murphy et al., 2006).”
MethodMSI-WES: A Simple Approach for Microsatellite Instability Testing using Whole Exome Sequencing
Ebili, H. O., Agboola, A. O., & Rakha, E. A. (2021) · Future Oncology · doi:10.2217/fon-2021-0132 · Cited by 8
Oh, N., Kim, H., Kim, K., Cheong, J., Lee, J., Noh, S. H., Sohn, T. S., Choi, Y. Y., & An, J. Y. (2021) · Annals of Surgical Oncology · doi:10.1245/s10434-021-10084-0 · Cited by 8
“If instability was observed in two or more markers, it was classified as MSI-high (MSI-H); otherwise, it was defined as microsatellite stable (MSS).(16,17)”
BackgroundColorectal cancer molecular profiling: from IHC to NGS in search of optimal algorithm
Furtado, L. V., & Samowitz, W. S. (2017) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-017-2153-8 · Cited by 8
Kong, P., Wu, R., Lan, Y., He, W., Yang, C., Yin, C., Yang, Q., Jiang, C., Xu, D., & Xia, L. (2017) · Journal of Cancer · doi:10.7150/jca.19810 · Cited by 8
“It has been reported that the rate of spontaneous mutation in microsatellites with multiple-nucleotide repeat units is more frequent than microsatellites with mono-nucleotide repeat units [12, 65].”
BackgroundShinozaki‐Ushiku, A., Kunita, A., Iwasaki, A., Kato, M., Yamazawa, S., Abé, H., & Ushiku, T. (2022) · Histopathology · doi:10.1111/his.14830 · Cited by 8
“MSI testing using the Promega panel has been reported to be superior to the Bethesda panel, and is widely used.(17,18) One of the advantages of this assay is that it can be performed without analysing normal tissue.”
MethodMLH1 Loss in Primary Prostate Cancer
Abadchi, S. N., Sena, L. A., Antonarakis, E. S., Pritchard, C. C., Eshleman, J. R., Konnick, E. Q., Salipante, S. J., Shenderov, E., & Lotan, T. L. (2023) · JCO Precision Oncology · doi:10.1200/po.22.00611 · Cited by 8
“Although the standard polymerase chain reaction (PCR) – based microsatellite instability (MSI) detection assay 6,7 lacks sensitivity for noncolorectal MMRd cancers, 3,8,9 a newer panel of long mononucleotide repeat (LMR) MSI markers shows improved performance, but is not yet widely used.”
Loss of heterozygosity (LOH)--implications for human genetic identification.
Pepiński, W., Sołtyszewski, I., Skawrońska, M., Rogowski, M., Zalewska, R., Kozłowski, L., Filipowski, T., & Janica, J. (2009) · Folia Histochemica et Cytobiologica · doi:10.2478/v10042-009-0019-x · Cited by 8
A cohort analysis of men with a family history of BRCA1/2 and Lynch mutations for prostate cancer
Kerr, L., Rewhorn, M., Longmuir, M., Fraser, S., Walsh, S. V., Andrew, N., & Leung, H. Y. (2016) · BMC Cancer · doi:10.1186/s12885-016-2573-x · Cited by 8
Clinical Actionability of Genes in Gastrointestinal Tumors
Gonzalez, N. S., Patelli, G., & Crisafulli, G. (2025) · Genes · doi:10.3390/genes16101130 · Cited by 7
“To determine microsatellite stability by PCR, the most commonly used routine test analyzes five mononucleotide loci: BAT-25, BAT-26, NR-21, NR-24, and MONO-27, and different kits may be used in the research setting, considering ten or more regions [23].”
Highly sensitive duplex MSI test and BAT40 germline polymorphism
Kang, S. Y., & Kim, K. (2021) · Apmis · doi:10.1111/apm.13170 · Cited by 7
Accurate measurement of microsatellite length by disrupting its tandem repeat structure
Wang, Z., Moffitt, A. B., Andrews, P., Wigler, M. H., & Levy, D. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac723 · Cited by 7
Różańska-Kudelska, M., Walenczak, I., Pepiński, W., Sieśkiewicz, A., Skawrońska, M., & Rogowski, M. (2008) · Advances in Medical Sciences · doi:10.2478/v10039-008-0023-y · Cited by 7
Dinjens, W. N. M., van Leerdam, M. E., & Wagner, A. (2010) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.10.37 · Cited by 7
Gallon, R., McCormick, L., Saetta, A. A., Albuquerque, C. M., Butler, S., Cranston, T., Field, J., McAnulty, C., Silva, P., Cheetham, M. H., et al. (2025) · European Journal of Human Genetics · doi:10.1038/s41431-025-01913-x · Cited by 8
Shahsiah, R., Salarvand, S., Miri, R., Ghalehtaki, R., & Rakhshani, N. (2017) · International Journal of Cancer Management · doi:10.5812/ijcm.11599 · Cited by 6
“Moreover, there is no need for simultaneous normal DNA matching because of the quasimonomorphic nature of pentaplex panel (9-12).”
BackgroundUnderstanding Colorectal Cancer: The Basics
Ghanta, M. K., Gursale, S. C., & Bhaskar, L. V. (2020) · Diagnostics and therapeutic advances in GI malignancies · doi:10.1007/978-981-15-2017-4_7 · Cited by 6
Choi, Y. Y., Jang, E., Kim, H., Kim, K., Noh, S. H., Sohn, T. S., Huh, Y., An, J. Y., & Cheong, J. (2021) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2021.05.05 · Cited by 6
Jass, J. R. (2006) · The Journal of Pathology · doi:10.1002/path.1933 · Cited by 6
“Dinucleotide markers are not as specific for MSI-High status as mononucleotide markers [6].”
BackgroundReynolds, T., Riddick, G., Meyers, G., Gordon, M., Monar, G. F. F., Moon, D., & Moon, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010472 · Cited by 1
“The molecular diagnosis of MSI is relatively simple and can currently be accomplished by examining PCR products amplified with a few (typically five to seven) informative microsatellite markers based on a polymerase chain reaction (MSI–PCR) [9,10].”
BackgroundMiyashita, K., Shioi, S., Kajitani, T., Koi, Y., Shimokawa, M., Makiyama, A., Oda, S., & Esaki, T. (2024) · Scientific Reports · doi:10.1038/s41598-024-77770-3 · Cited by 5
Herz, A., Wisser, S., Kohlruss, M., Slotta‐Huspenina, J., Jesinghaus, M., Grosser, B., Steiger, K., Novotny, A., Hapfelmeier, A., Schmidt, T., et al. (2022) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.257 · Cited by 5
“The classical term MSI usually refers to instability determined at mono-and dinucleotide repeat markers using standardised panels comprising in general fi ve microsatellite markers [3,4].”
MethodLiquid Biopsy in Advanced Colorectal Cancer: Clinical Applications of Different Analytes
Delcuratolo, M. D., Modrego-Sánchez, A., Bungaro, M., Antón-Pascual, B., Terán, S., Dipace, V., Novello, S., García‐Carbonero, R., Passiglia, F., & Graválos-Castro, C. (2023) · Journal of Molecular Pathology · doi:10.3390/jmp4030013 · Cited by 5
Davis, J. L., Grenert, J. P., & Horvai, A. (2014) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2013-0236-oa · Cited by 5
Mamdouh, S., Metwally, A. M., Aref, A., Khaled, H. M., Hammam, O. A., & Saber, M. (2015) · American Journal of Biochemistry · Cited by 5
Off-label use of common predictive biomarkers in gastrointestinal malignancies: a critical appraisal
Tessier‐Cloutier, B., Cai, E., & Schaeffer, D. F. (2019) · Diagnostic Pathology · doi:10.1186/s13000-019-0843-z · Cited by 5
“[27] In extracolonic malignancies, MMR deficiency is most”
BackgroundSingh, A., Jindal, S., Soni, A., Kaur, H., Jain, K., Vikram, N., Sumit, G., Garg, B., & Ramneek, K. (2022) · Indian Journal of Surgical Oncology · doi:10.1007/s13193-022-01633-4 · Cited by 4
Wu, S., Qian, X., Yu, X., Sheng, H., & Lü, B. (2012) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0b013e3182434174 · Cited by 4
He, L., Yang, J. H., Zhang, B., Wang, Y., Wang, J., & Ye, Q. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154390 · Cited by 4
Dasanu, C. A., AL-ANI, M. S. M., Habibi, S., & Codreanu, I. (2023) · Journal of Oncology Pharmacy Practice · doi:10.1177/10781552231178293 · Cited by 4
Fan, X., Bai, Q., Shi, C., Xiao, Y., & Wang, X. (2023) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2023.2257133 · Cited by 4
“The Promega panel includes five mononucleotide repeats (BAT-25, BAT-26, NR-21, NR-24, and MONO-27) [23].”
BackgroundHyperplastic Polyps Are Innocuous Lesions in Hereditary Nonpolyposis Colorectal Cancers
Speake, D., O’Sullivan, J., Evans, D. G., Lalloo, F. I., Hill, J., & McMahon, R. F. (2011) · International Journal of Surgical Oncology · doi:10.1155/2011/653163 · Cited by 4
“Microsatellite analysis was performed using previously described techniques [26, 27].”
MethodPrecision length determination and in silico simulation in PCR of microsatellite repeat sequences
Shioi, S., Shimamoto, A., Nakagami, Y., Qin, L., Shimokawa, M., & Oda, S. (2021) · Electrophoresis · doi:10.1002/elps.202100021 · Cited by 4
Saller, J. J., Qin, D., Felder, S. I., & Coppola, D. (2020) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2020.02.003 · Cited by 4
Metadata
- Authors
- Bacher, J. W., Flanagan, L. A., Smalley, R. L., Nassif, N. A., Burgart, L. J., Halberg, R. B., Megid, W. M. A., & Thibodeau, S. N.
- Affiliations
- Promega (United States) (US)
- Mayo Clinic (US)
- Corresponding author
- Bacher, Jeffery W.
- Venue
- Disease Markers
- Publisher
- Wiley
- Published
- 2004-01
- Volume
- 20
- Issue
- 4-5
- Pages
- 237-250
- ISSN
- 0278-0240 (ISSN-L)
- 1875-8630
- PMC
- PMC3839403
- OpenAlex
- W2104818405
- Cited by
- 276
- References
- 49
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 15 · 2023: 20 · 2022: 16 · 2021: 33 · 2020: 21 · 2019: 11 · 2018: 19 · 2017: 13 · 2016: 10 · 2015: 11 · 2014: 9 · 2013: 9 · 2012: 10
- FWCI
- 5.14
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Disease Markers (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health (CA-76834)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Health Sciences › Medicine › Oncology › Colorectal Cancer Surgical Treatments
- Keywords
- microsatellite instability, mismatch repair deficiency, Lynch syndrome, BAT25, BAT26, colorectal neoplasia, gastrointestinal cancer
- MeSH terms
- Alleles, Colorectal Neoplasms, Hereditary Nonpolyposis, DNA Mutational Analysis, Fluorescent Dyes, Gastrointestinal Neoplasms, Gene Frequency, Humans, Immunohistochemistry, Microscopy, Fluorescence, Mutation, Oligonucleotides, Phenotype, Prognosis, Sensitivity and Specificity, Biomarkers, Tumor, Colorectal Neoplasms, Polymerase Chain Reaction, Microsatellite Repeats, DNA Sequence, Unstable
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.